{"DataElement":{"publicId":"5936800","version":"1","preferredName":"Gleason Primary Score For Prostate Cancer Category","preferredDefinition":"The Primary Gleason score as defined by the most prevalent Gleason pattern in a prostate biopsy or prostatectomy specimen.","longName":"PRM_GLEASO_SC_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2782935","version":"1","preferredName":"Gleason Score Primary Gleason Score For Prostate Cancer","preferredDefinition":"A system of grading prostate cancer cells to determine the best treatment and to predict how well a person is likely to do. A low Gleason score means the cancer cells are very similar to normal prostate cells; a high Gleason score means the cancer cells are very different from normal. _definition pending","longName":"2547908v1.0:2431249v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2547908","version":"1","preferredName":"Gleason Score for Prostate Cancer","preferredDefinition":"The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","longName":"C28084","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Score for Prostate Cancer","conceptCode":"C28084","definition":"The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"23681B08-081C-19C0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-29","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-11-29","modifiedBy":"SBREXT","dateModified":"2017-08-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2431249","version":"1","preferredName":"Primary Gleason Score For Prostate Cancer","preferredDefinition":"definition pending","longName":"C48603","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Gleason Pattern","conceptCode":"C48603","definition":"The most prevalent Gleason pattern in a prostate biopsy or prostatectomy specimen. The Gleason score is defined by adding the most prevalent (primary) and second most prevalent (secondary) patterns.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCE7F0-E041-3560-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5691D366-7A38-1E65-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-10","endDate":null,"createdBy":"UMLLOADER_CATISSUE","dateCreated":"2008-09-10","modifiedBy":"TAYLORT","dateModified":"2017-08-23","changeDescription":"9/28/10 Released for use in caTissue Suite version 1.1 and/or 1.2 per owners direction.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5936783","version":"1","preferredName":"Gleason Score for Prostate Cancer Category","preferredDefinition":"The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable._A grouping of items based on some commonality or by user defined characteristics","longName":"5936783v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"NUMBER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":"Gleason Pattern 1","ValueMeaning":{"publicId":"2925235","version":"1","preferredName":"Gleason Pattern 1","longName":"2925235","preferredDefinition":"A pattern of prostate carcinoma characterized by the presence of a well circumscribed nodule of separate glands which are closely packed. There is no infiltration of the surrounding parenchyma. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Pattern 1","conceptCode":"C28085","definition":"A pattern of prostate carcinoma characterized by the presence of a well circumscribed nodule of separate glands which are closely packed. There is no infiltration of the surrounding parenchyma. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FDC7D18-C13D-DC43-E040-BB89AD431DD5","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"576E72DD-5F11-3C5F-E053-F662850A5B33","beginDate":null,"endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-23","modifiedBy":"ONEDATA","dateModified":"2017-08-23","deletedIndicator":"No"},{"value":"2","valueDescription":"Gleason Pattern 2","ValueMeaning":{"publicId":"2925236","version":"1","preferredName":"Gleason Pattern 2","longName":"2925236","preferredDefinition":"A pattern of prostate carcinoma characterized by the presence of glands that are more loosely arranged and less uniform compared to Gleason pattern 1. Minimal invasion of the surrounding parenchyma may be present. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Pattern 2","conceptCode":"C28086","definition":"A pattern of prostate carcinoma characterized by the presence of glands that are more loosely arranged and less uniform compared to Gleason pattern 1. Minimal invasion of the surrounding parenchyma may be present. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FDC7D18-C15F-DC43-E040-BB89AD431DD5","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"576E72DD-5F1B-3C5F-E053-F662850A5B33","beginDate":null,"endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-23","modifiedBy":"ONEDATA","dateModified":"2017-08-23","deletedIndicator":"No"},{"value":"3","valueDescription":"Gleason Pattern 3","ValueMeaning":{"publicId":"2925237","version":"1","preferredName":"Gleason Pattern 3","longName":"2925237","preferredDefinition":"A pattern of prostate carcinoma characterized by the presence of glands that are infiltrative and vary in size and shape. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Pattern 3","conceptCode":"C28087","definition":"A pattern of prostate carcinoma characterized by the presence of glands that are infiltrative and vary in size and shape. The epithelial polarity of the malignant cells is preserved and luminal differentiation is present in all glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FDC7D18-C181-DC43-E040-BB89AD431DD5","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"576E72DD-5F25-3C5F-E053-F662850A5B33","beginDate":null,"endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-23","modifiedBy":"ONEDATA","dateModified":"2017-08-23","deletedIndicator":"No"},{"value":"4","valueDescription":"Gleason Pattern 4","ValueMeaning":{"publicId":"2925238","version":"1","preferredName":"Gleason Pattern 4","longName":"2925238","preferredDefinition":"A pattern of prostate carcinoma characterized by the presence of fused, cribriform, or poorly defined glands. There is partial loss of normal epithelial polarity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Pattern 4","conceptCode":"C28088","definition":"A pattern of prostate carcinoma characterized by the presence of fused, cribriform, or poorly defined glands. There is partial loss of normal epithelial polarity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FDC7D18-C1A3-DC43-E040-BB89AD431DD5","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"576E72DD-5F2F-3C5F-E053-F662850A5B33","beginDate":null,"endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-23","modifiedBy":"ONEDATA","dateModified":"2017-08-23","deletedIndicator":"No"},{"value":"5","valueDescription":"Gleason Pattern 5","ValueMeaning":{"publicId":"2925239","version":"1","preferredName":"Gleason Pattern 5","longName":"2925239","preferredDefinition":"A pattern of prostate carcinoma characterized by almost complete loss of epithelial polarity and luminal differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Pattern 5","conceptCode":"C28089","definition":"A pattern of prostate carcinoma characterized by almost complete loss of epithelial polarity and luminal differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FDC7D18-C1C5-DC43-E040-BB89AD431DD5","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-07-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"576E72DD-5F39-3C5F-E053-F662850A5B33","beginDate":null,"endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-23","modifiedBy":"ONEDATA","dateModified":"2017-08-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5936782","version":"1","preferredName":"Gleason Score for Prostate Cancer Category","preferredDefinition":"The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C28084:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Score for Prostate Cancer","conceptCode":"C28084","definition":"The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"576E72DD-5EE7-3C5F-E053-F662850A5B33","latestVersionIndicator":"Yes","beginDate":"2017-08-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-23","modifiedBy":"ONEDATA","dateModified":"2017-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"576E72DD-5EF8-3C5F-E053-F662850A5B33","latestVersionIndicator":"Yes","beginDate":"2017-08-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-23","modifiedBy":"TAYLORT","dateModified":"2017-08-23","changeDescription":"8/23/17 tt new VD due to data type, added CSI and released per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5915896","version":"1","longName":"Gross Pathology","context":"NCI Standards"}]}],"AlternateNames":[{"name":"Theradex","type":"USED_BY","context":"Theradex"},{"name":"MI_MIORRES_GLSN_PRM_PATT","type":"OID, CCTG","context":"CCTG"}],"ReferenceDocuments":[{"name":"Primary Gleason grade","type":"Preferred Question Text","description":"Primary Gleason grade","url":null,"context":"NCI Standards"},{"name":"Round5","type":"Alternate Question Text","description":"Primary Gleason score","url":null,"context":"NCI Standards"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Primary Gleason grade at initial diagnosis","url":null,"context":"Theradex"},{"name":"CCTG_01","type":"Alternate Question Text","description":"Primary Gleason pattern","url":null,"context":"CCTG"}],"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"576DD093-201A-6904-E053-F662850A8A34","latestVersionIndicator":"Yes","beginDate":"2017-08-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-23","modifiedBy":"CLOHNES","dateModified":"2023-11-16","changeDescription":"8/23/17 tt Draft New CDE upd with new VD and released per Round 5 finalization task.","administrativeNotes":"11/16/23 Added alt OID and AQT for CCTG ticket number CADSR0003085 cjl","unresolvedIssues":null,"deletedIndicator":"No"}}